The 3.8% rate of confirmed VTE within 100 days post-discharge in high-risk elderly medical patients highlights a potential gap in extended thromboprophylaxis.
No takes yet. Share an insight, caveat, or question.
May warrant targeted prophylaxis trials in high-risk elderly; hypothesis-generating without randomized confirmation.
Hull et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: